CLINICAL ANALYSIS AND MANAGEMENT OF RHINO-ORBITO-CEREBRAL MUCORMYCOSIS IN 2ND WAVE OF COVID-19 IN TERTIARY CARE CENTRE

Main Article Content

PRAJAKTA PATIL
DEVIKA DAMLE
SUPRIYA BHAVAKE
SANVEDYA KADAM

Abstract

The present study mainly deals with the patients manifesting with mucormycosis (BLACK FUNGUS) in 2ND Wave of COVID-19 patients. Rhino-orbito-cerebral ucormycosis is an uncommon infection caused by the angiotropic fungus belonging to the order Mucorales. The study involves case series of 14 patients with average age group from 35 to 65 years showing male predominance diagnosed and treated with rhino-orbital-cerebral mucormycosis in COVID-19 in Krishna hospital, Karad from April 2021 to May 2021. The symptoms of rhino-orbital cerebral mucormycosis are often non-specific with varying spectrum and severity. All patients studied in this series were non vaccinated for COVID-19. Post vaccination presentation of mucormycosis warrants further study. Hence, early diagnosis and prompt treatment can reduce the mortality and morbidity of this lethal fungal infection.

Keywords:
Black fungus, vaccination, Rhino-orbito-cerebral mucormycosis, COVID-19

Article Details

How to Cite
PATIL, P., DAMLE, D., BHAVAKE, S., & KADAM, S. (2021). CLINICAL ANALYSIS AND MANAGEMENT OF RHINO-ORBITO-CEREBRAL MUCORMYCOSIS IN 2ND WAVE OF COVID-19 IN TERTIARY CARE CENTRE. PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY, 22(71-72), 332-336. Retrieved from https://ikprress.org/index.php/PCBMB/article/view/7299
Section
Original Research Article

References

Revzin MV, Raza S, Warshawsky R, D’agostino C, Srivastava NC, Bader AS, Pellerito JS. Multisystem imaging manifestations of COVID-19, part 1: viral pathogenesis and pulmonary and vascular system complications. Radiographics. 2020;40(6):1574-1599.

Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and eye: A review of ophthalmic manifestations of COVID-19. Indian Journal of Ophthalmology. 2021; 69(3):488.

Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian Journal of Ophthalmology. 2021;69(2):244.

Toumi A, Ammari FL, Loussaief C, Hadhri R, Brahim HB, Harrathi K, Chakroun M. Rhino-orbito-cerebral mucormycosis: five cases. Médecine et Maladies Infectieuses. 2012;42(12):591-598.

Mahalaxmi I, Jayaramayya K, Venkatesan, D, Subramaniam MD, Renu K, Vijayakumar P, Vellingiri B. Mucormycosis: An opportunistic pathogen during COVID-19. Environmental Research. 2021;111643.

Binder U, Maurer E, Lass‐Flörl C. Mucormycosis–from the pathogens to the disease. Clinical Microbiology and Infection. 2014 Jun;20:60-6.

Chennamchetty VK, Adimulapu S, Kola BP, Rao MR. Post-COVID pulmonary mucormycosis-a case report. Ind J Immunol Respir Med. 2021;6(1):62-6.

AK AK, Gupta V. Rhino-orbital Cerebral Mucormycosis. StatPearls [Internet]; 2021.

Ajith Kumar AK, Gupta V. Rhino-orbital Cerebral Mucormycosis.

Chakrabarti A, Singh R. Mucormycosis in India: unique features. Mycoses. 2014;57, 85-90.